Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;126 Suppl 6(Suppl 6):56-65.
doi: 10.1111/bcpt.13277. Epub 2019 Jul 9.

Come Fly with Me: An overview of dopamine receptors in Drosophila melanogaster

Affiliations
Review

Come Fly with Me: An overview of dopamine receptors in Drosophila melanogaster

Caline S Karam et al. Basic Clin Pharmacol Toxicol. 2020 Jun.

Abstract

Dopamine (DA) receptors play critical roles in a wide range of behaviours, including sensory processing, motor function, reward and arousal. As such, aberrant DA signalling is associated with numerous neurological and psychiatric disorders. Therefore, understanding the mechanisms by which DA neurotransmission drives intracellular signalling pathways that modulate behaviour can provide critical insights to guide the development of targeted therapeutics. Drosophila melanogaster has emerged as a powerful model with unique advantages to study the mechanisms underlying DA neurotransmission and associated behaviours in a controlled and systematic manner. Many regions in the fly brain innervated by dopaminergic neurons have been mapped and linked to specific behaviours, including associative learning and arousal. Here, we provide an overview of the homology between human and Drosophila dopaminergic systems and review the current literature on the pharmacology, molecular signalling mechanisms and behavioural outcome of DA receptor activation in the Drosophila brain.

Keywords: GPCR signalling; G protein-coupled receptors; dopamine; neuropharmacology; psychopharmacology.

PubMed Disclaimer

Conflict of interest statement

Disclosure Statement:

The authors have nothing to disclose.

References

    1. Hauser AS, Attwood MM, Rask-Andersen M, et al. Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov 2017; 16: 829–842. - PMC - PubMed
    1. Stahl SM. Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes. CNS Spectr 2017; 22: 375–384. - PubMed
    1. Klein MO, Battagello DS, Cardoso AR, et al. Dopamine: Functions, Signaling, and Association with Neurological Diseases. Cell Mol Neurobiol 2019; 39: 31–59. - PMC - PubMed
    1. Beaulieu J-M, Espinoza S, Gainetdinov RR. Dopamine receptors – IUPHAR Review 13. Br J Pharmacol 2015; 172: 1–23. - PMC - PubMed
    1. Wisler JW, Xiao K, Thomsen ARB, et al. Recent developments in biased agonism. Curr Opin Cell Biol 2014; 27: 18–24. - PMC - PubMed

LinkOut - more resources